Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor activator. This breakthrough approach holds significant promise for controlling type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and reduces glucagon release, leading to improved blood sugar control. Clinical trials have